Tenax Therapeutics (TENX) Other Non Operating Income (2011 - 2026)

Tenax Therapeutics has reported Other Non Operating Income for 16 years, with the latest figure at -$4000.0 in Q1 2026.

• Other Non Operating Income for Q1 2026 came in at -$4000.0, changed N/A year-over-year; the trailing twelve-month figure through Jun 2026 was -$28000.0 (down 281.16% YoY), and the FY2025 annual result was -$33000.0, down 3400.0% from the prior year.
• Other Non Operating Income advanced to -$4000.0 in Q1 2026, from -$9000.0 in the prior quarter.
• Over five years, Other Non Operating Income peaked at $125866.0 in Q4 2023 and troughed at -$140055.0 in Q1 2023.
• A 5-year average of -$12442.9 and a median of -$3146.0 in 2022 frame the typical range for Other Non Operating Income.
• The largest YoY upside for Other Non Operating Income was 2261.53% in 2023 against a maximum downside of 45279.03% in 2023.
• A 5-year view of Other Non Operating Income shows it stood at -$5823.0 in 2022, then surged by 2261.53% to $125866.0 in 2023, then plunged by 98.69% to $1654.0 in 2024, then sank by 644.14% to -$9000.0 in 2025, then surged by 55.56% to -$4000.0 in 2026.
• Per Business Quant data, the three most recent Other Non Operating Income figures were -$4000.0 in Q1 2026, -$9000.0 in Q4 2025, and -$15000.0 in Q3 2025.